Novo Will Slash US List Prices for Wegovy, Ozempic Next Year

Novo Nordisk A/S plans to slash the US list prices for its blockbusters Wegovy and Ozempic next year as the drugmaker struggles to claw back a larger share of the obesity market....

Redirecting to full article...